Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, August 31, 2014
Technology Networks
Register | Sign in
Home Page>Posters


Indirubin inhibitors of Leishmania mexicana CRK3 Cyclin Dependent Kinase
Dawn Taylor, Karen M. Grant and Nicholas J. Westwooda

The indirubins are known inhibitors of cyclin dependent kinases (CDKs), including CRK3 from the protozoan parasite Leishmania mexicana, which is essential for proliferation of the disease Leishmaniasis. Subsequent investigations into the pharmacological properties of the indirubins show them to be competitive ATPbinding site inhibitors of the CDKs.

Analytical Sample Transport – A Pneumatic Solution
Matthew Cook, Bob Lawson and Paul Martin

Pneumatic air transport systems can provide a safe, efficient and rapid means of sending samples within different departments of a research laboratory. These systems are often used within a hospital, supermarket or bank and represent an effective method for sending samples or packages to different departments. TTP LabTech has used this technology for over 6 years, predominately in our comPILER and comPOUND systems.

Intelligent K-Means Clustering in a Multiple Endpoint Environment
E. Kolossov

The main success of QSAR predictive technology is mainly related to the modelling of the single activity/property endpoint in chemical space. Unfortunately an optimisation of the targeted endpoint may result in losing other desired properties, for example, toxicity is increased or solubility reduced. Because of this, attempts have been made in the last few years to model chemical space against multiple endpoints.

Screening Solution: ActivityBase™
Jonathan Davies and Andrew English

The data management needs of discovery biology are complex and varied. The experimental data that is captured, stored and analyzed ranges from high volume, routine screening data through to low throughput, non-routine test management data that underpins pre-clinical research. ActivityBase™ is a data management system that integrates research data in a structured and scalable environment, providing secure management of a discovery organization’s principle asset – data.

Comparative Virtual and Experimental High-Throughput Screening for Glycogen Synthase Kinase-3b Inhibitors
György M. Keser, Tímea Polgár, Andrea Baki and Györgyi I. Szendrei

Glycogen synthase kinase-3b (GSK-3b ) is a serine/threonine kinase that has recently emerged as a key target for neurodegenerative diseases and diabetes. As an initial step of our lead discovery program we developed a virtual screen to discriminate known GSK-3b inhibitors and inactive compounds using FlexX, FlexX-Pharm and FlexE.

Communicating Drug Discovery Data Efficiently and Effectively
Jonathan Davies and Andrew Lemon

In this poster, we present IDBS’ ActivityBase™ - a single, integrated framework that brings together biological and chemical information. The software integrates with Oracle®, the industry standard relational database and familiar Microsoft® applications such as Word and Excel. With all discovery data in one system, the communication of information between scientists is simplified - enabling better, faster decisions and the need for IT support to integrate disparate systems is eliminated.

Microwave Accelerated Heterogeneous Catalysis – Flow-Through Reactor Concept and Application
T. Glasnov, K. Mennecke, R. Cecillia, U. Kunz, A. Kirschning and C.O. Kappe,

Flow-through processes in organic synthesis become more important as an enabling technology for a cost effective and convenient method. This requires appropriate reactors with functionalities for organic reactions. In this project noble metal-loaded polymer/carrier reactors able to be operated in a microwave field were investigated. By application of a microwave field metal sites are heated whereas the polymer/carrier material remains transparent to irradiation.

Achieving Ultra High Performance Screening
David James Morris, Steve Mayhew and William Hoyland

High throughput (HT) and Ultra High Throughput (UHT) screening remains a valuable and necessary approach to modern drug discovery. Successful application of HTS requires accurate and meaningful handling of the experimental results. This means capturing vast data volumes generated by HTS and UHTS programmes and subsequent validation and verification. Decision making regarding HTS data can be supported via comprehensive and intuitive visualization of results.

Study Management in Late Stage Discovery and Preclinical Research
Glyn Williams and Paul Denny-Gouldson

Organizations need to streamline their operations by managing the entire lifecycle of an experiment - from design to final publication of data. Organizations require the full benefits of IP protection, with the ability to access a solution for data capture, reduction, statistical analysis, charting and data curation. Researchers want a familiar notebook interface that they can use to create and manage study reports and publish data to corporate warehouses and document systems.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 142
Scientific News
Cancer-Fighting Drugs Might Also Stop Malaria Early
A number of compounds have been identified which could be used to fight malaria.
Collaboration Leads to Possible Shortcut to New Drugs
The reaction, reported in Science, demonstrates how a carboxylic acid can be transformed into a very reactive site through use of a novel photoredox catalyst.
Catalysts That Mimic Enzymes Could Revolutionize Pharmaceutical Manufacturing
Structures made of polymer chains allow the catalysts to work in water.
Discovery of How Taxol Works Could Lead to Better Anticancer Drugs
The drug’s interference with the normal function of microtubules could help in designing better anticancer drugs.
Chemists Discover Cancer Drug Candidate Structure
Chemists at The Scripps Research Institute have determined the correct structure of a highly promising anticancer compound approved by the U.S. FDA for clinical trials in cancer patients.
Novel Drug Targets for Allergy Identified
Researchers have identified several target molecules which are suitable for the development of new allergy drugs.
Drug Does Not Improve Set of Cardiovascular Outcomes for Diastolic Heart Failure
NIH-supported study finds drug does appear to reduce hospitalizations for diastolic heart failure.
Entirely Novel Strategy to Molecular Anticancer Therapy Tricks Malignant Cells
New drug prevents tumour growth by inhibiting the nucleotide sanitizing enzyme MTH1.
New Trial of Personalized Cancer Treatment Begins in Oxford
Phase I trial in Oxford will investigate a new drug, called CXD101.
Flow Microreactor Synthesis in Organo-Fluorine Chemistry
This review focuses on successful examples on synthesis and reactions of fluorine-containing molecules by the use of flow microreactor systems.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to